摘要
目的 探讨康莱特注射液对联合化疗与单纯化疗改善晚期非小细胞肺癌 (NSCL C)患者的生活质量临床意义。方法 采取随机对照分组 ,治疗组 30例为康莱特联合化疗 ;对照组 30例为单纯化疗。结果 治疗组有效率为 36 .7% ,对照组为 2 3.3% ,有显著性差异 (P<0 .0 5 ) ,在控制疼痛、体重及 karnofsky评分等方面治疗组均优于对照组 ,差异有显著性。结论 康莱特注射液联合化疗可提高化疗疗效。
Objective To evaluate the clinical significance of chemotherapy with and without kanglaite in the non-small cell lung cancer (NSCLC) patients to improve their quality of life.Methods The treatment group received Kanglaite and chemotherapy, and the control group received simple chemotherapy . The two groups were enrolled by a randomly contrast method. Results The effective rate in the treatment group was 36.7% ,in the control group it was 23.3: p<0.05. There was a greater improvement for the treatment group on pain, weight and karnofsky.Conclusion Kanglaite combined with chemotherapy can enhance the therapeutic effect, and improve the quality of life in NSCLC patients.
出处
《临床肺科杂志》
2004年第4期342-343,共2页
Journal of Clinical Pulmonary Medicine
